Compounds > dihydrotestosterone
Page last updated: 2024-08-21

dihydrotestosterone and Triple Negative Breast Neoplasms

dihydrotestosterone has been researched along with Triple Negative Breast Neoplasms in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (58.33)24.3611
2020's5 (41.67)2.80

Authors

AuthorsStudies
Abdullah, MS; Ahram, M; Alsafadi, DB; Battah, AH; Mustafa, SA1
Abdullah, MS; Ahram, M; Alsawalha, L; Dalmizrak, O1
Feng, W; Gan, L; Gao, M; He, T; Li, X; Liu, X; Wu, X; Yang, M1
Chang, G; Chen, S; Huang, MJ; Kanaya, N; Petrossian, K; Saeki, K; Somlo, G; Wang, X1
Ahram, M; Al-Momany, B; Hammad, H1
Guan, X; Liu, Y; Shen, Y; Song, W; Yang, F; Zhang, W1
Ahram, M; Al-Othman, N; Hammad, H1
Abe, E; Brown, KA; Hirakawa, H; Ishida, T; McNamara, KM; Miki, Y; Miyashita, M; Nakamura, Y; Nemoto, N; Nurani, AM; Ohuchi, N; Sasano, H; Shibahara, Y; Suzuki, K; Suzuki, T; Tamaki, K; Wang, L; Yang, Y; Yoda, T1
Arteaga, CL; Balko, JM; Bauer, JA; Chen, X; Gómez, H; Johnson, KC; Lehmann, BD; Mills, GB; Pendleton, CS; Pietenpol, JA; Sanders, ME; Schafer, JM; Tang, L1
Guan, X; Li, Y; Song, W; Xu, Y; Yang, F; Yin, Y; Zhang, W; Zhu, A1
Buchwald, P; Ince, TA; Picon-Ruiz, M; Thakkar, A; Wang, B1
Butterfield, KT; Christenson, JL; Josan, JS; Katzenellenbogen, BS; Katzenellenbogen, JA; McDonnell, DP; Norris, JD; Pollock, JA; Richer, JK; Spoelstra, NS1

Other Studies

12 other study(ies) available for dihydrotestosterone and Triple Negative Breast Neoplasms

ArticleYear
Androgen downregulates desmocollin-2 in association with induction of mesenchymal transition of breast MDA-MB-453 cancer cells.
    Cytoskeleton (Hoboken, N.J.), 2021, Volume: 78, Issue:8

    Topics: Androgens; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Desmocollins; Dihydrotestosterone; Epithelial-Mesenchymal Transition; Female; Humans; Triple Negative Breast Neoplasms

2021
Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:17

    Topics: Benzamides; Caspase 3; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; DNA; Doxorubicin; Drug Resistance, Neoplasm; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Nitriles; Phenylthiohydantoin; Triple Negative Breast Neoplasms

2022
HC-1119, a deuterated Enzalutamide, inhibits Migration, Invasion and Metastasis of the AR-positive triple-negative breast Cancer cells.
    Molecular biology reports, 2022, Volume: 49, Issue:10

    Topics: Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Humans; Mice; Neoplasm Recurrence, Local; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Receptors, Estrogen; Triple Negative Breast Neoplasms

2022
Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer.
    The Journal of steroid biochemistry and molecular biology, 2021, Volume: 206

    Topics: Androgen Receptor Antagonists; Androgens; Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Mice; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Signal Transduction; Triple Negative Breast Neoplasms

2021
Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Current molecular pharmacology, 2021, Volume: 14, Issue:5

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Neoplasm Proteins; Triple Negative Breast Neoplasms

2021
The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 43, Issue:5

    Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; Dihydrotestosterone; Female; Humans; Immunohistochemistry; Protein Binding; Real-Time Polymerase Chain Reaction; Receptor, ErbB-2; Receptors, Androgen; Receptors, Estrogen; Signal Transduction; Triple Negative Breast Neoplasms

2017
Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene, 2018, Oct-30, Volume: 675

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dihydrotestosterone; Female; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; MicroRNAs; Triple Negative Breast Neoplasms

2018
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes.
    Breast cancer research and treatment, 2014, Volume: 145, Issue:2

    Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androgens; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Cell Line, Tumor; Cell Proliferation; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxyprostaglandin Dehydrogenases; Keratin-5; Keratin-6; Receptors, Androgen; Triple Negative Breast Neoplasms

2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.
    Breast cancer research : BCR, 2014, Aug-08, Volume: 16, Issue:4

    Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Cluster Analysis; Dihydrotestosterone; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Receptors, Androgen; Signal Transduction; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2014
Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:3

    Topics: Anilides; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Mice; Neoplasm Transplantation; Nitriles; Receptors, Androgen; Tosyl Compounds; Triple Negative Breast Neoplasms; Tumor Protein p73

2016
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer.
    Breast cancer research and treatment, 2016, Volume: 157, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydrotestosterone; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Molecular Targeted Therapy; Receptors, Androgen; Receptors, Calcitriol; Triple Negative Breast Neoplasms

2016
MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Hormones & cancer, 2017, Volume: 8, Issue:2

    Topics: Androgen Antagonists; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Dihydrotestosterone; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Receptors, Androgen; Triple Negative Breast Neoplasms

2017